Teladoc Health (NYSE:TDOC) Given New $8.00 Price Target at Evercore ISI

Teladoc Health (NYSE:TDOC - Get Free Report) had its price target hoisted by equities research analysts at Evercore ISI from $7.00 to $8.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an "in-line" rating on the health services provider's stock. Evercore ISI's price objective would indicate a potential downside of 10.06% from the stock's current price.

TDOC has been the subject of several other reports. Jefferies Financial Group lowered their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research note on Monday, April 21st. The Goldman Sachs Group lowered their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Truist Financial lowered their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Finally, Wells Fargo & Company reduced their price objective on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research note on Thursday, May 8th. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $9.65.

Teladoc Health Price Performance

TDOC traded up $0.05 during midday trading on Wednesday, hitting $8.90. The company had a trading volume of 3,760,347 shares, compared to its average volume of 6,389,089. Teladoc Health has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a market capitalization of $1.56 billion, a PE ratio of -1.50 and a beta of 1.84. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.64 and a current ratio of 1.68. The firm's 50-day simple moving average is $7.41 and its 200-day simple moving average is $8.68.

Insider Buying and Selling at Teladoc Health

In other news, insider Fernando M. Rodrigues sold 4,174 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the sale, the insider owned 69,773 shares in the company, valued at $478,642.78. This trade represents a 7.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock valued at $128,189 in the last 90 days. 0.58% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Baader Bank Aktiengesellschaft acquired a new position in shares of Teladoc Health during the 2nd quarter worth about $95,000. Strs Ohio acquired a new position in Teladoc Health during the first quarter valued at approximately $349,000. Acadian Asset Management LLC bought a new position in Teladoc Health in the first quarter valued at approximately $615,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Teladoc Health by 5.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider's stock worth $3,566,000 after purchasing an additional 24,124 shares during the last quarter. Finally, NewEdge Advisors LLC raised its stake in shares of Teladoc Health by 1,278.7% during the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock worth $90,000 after purchasing an additional 10,485 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.